Anti-Krebs-Mittel hat jeder zu Hause: Harvard-Forscher scores a single einfachen Mittel

Forscher from Harvard University has investigated what an effective aspirin is in reducing intestinal risks. Once the party has started, it’s as if there’s an aspirin in the Krebsrisiko form.

The study will take place at the Massachusetts General Hospital, Harvard University’s largest Lehrkrankenhaus, during the study. Since more than 100,000 patients have been analyzed, the regular aspirin attacks are carried out. The data used by individuals cannot contain aspirin. The study instruction would last a period of 30 years.

The Forscher has herausgefunden, man, the regular aspirin is used, seltener and Krebs erkranken. I have a term of 10 years with the Aspirin Patients at 1.98 Prozent, which means that the Nicht-Aspirin Patients at 2.95 Prozent liegt. When the risk is reached, it has become 32 percent cheaper.

In addition to the German war on persons, raising a number of life forms poses a high degree of risk for the Darmkrebs. You can make gains by taking aspirin regularly. If the “untreated” aspirin patients are treated with 10-year-inzidenz 2.12 percent, what will happen in the non-aspirin patients at 3.4 percent. There is a risk reduction of 37.6 Prozent.

Even in silent individuals, the action of aspirin can have a positive effect, if German, if the expert is good at it. In these individuals, it has been 10 years since the aspirin patients took 1.5 percent of the 1.6 percent dose in non-aspirin patients. The target of a risk reduction is 6 Prozent.